Skip to main content
Premium Trial:

Request an Annual Quote

Germany s IBA to Resell Exiqon s Locked Nucleic Acid Technology

NEW YORK, May 4 (GenomeWeb News) - Exiqon today said that IBA, a Goettingen, Germany-based life science tool provider, has licensed its Locked Nucleic Acid (LNA) technology for resale in the genomics research market.

IBA (originally founded as the non-profit Institut f r Bioanalytik) acquired non-exclusive rights to manufacture and sell LNA oligonucleotides.

Financial terms of the agreement were not disclosed.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.